ImmuCell Corporation
ICCC
$5.07
-$0.0662-1.29%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 62.65% | 39.53% | 32.71% | 26.77% | -131.56% |
| Total Depreciation and Amortization | -1.10% | 1.58% | 5.25% | 8.11% | 9.22% |
| Total Amortization of Deferred Charges | 88.50% | 190.97% | 423.68% | 306.58% | 197.37% |
| Total Other Non-Cash Items | -59.55% | -44.06% | -1.26% | 14.21% | 64.47% |
| Change in Net Operating Assets | 80.75% | 122.18% | 123.11% | 69.75% | -15.23% |
| Cash from Operations | 107.66% | 93.10% | 96.16% | 69.79% | -202.78% |
| Capital Expenditure | 75.39% | 89.37% | 81.11% | 66.74% | 52.39% |
| Sale of Property, Plant, and Equipment | 80.00% | 80.00% | 6,800.00% | -- | -77.27% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 200.00% | -- | -- | -- |
| Cash from Investing | 75.60% | 93.23% | 81.30% | 66.80% | 52.32% |
| Total Debt Issued | -- | -100.00% | 300.00% | 300.00% | 150.00% |
| Total Debt Repaid | 53.91% | 52.85% | -249.72% | -246.54% | -255.12% |
| Issuance of Common Stock | 24,622.87% | -- | -- | -24.19% | -38.56% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -264.17% | 111.82% | -- | -17,200.00% | -322.28% |
| Cash from Financing | 64.60% | 32.22% | 2,957.87% | 769.40% | 57.20% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 157.75% | 126.60% | 98.64% | 75.51% | -9.53% |